Press Release

Multiple Myeloma Market Size 2020 | North America, Europe & Asia Pacific Regions to Dominate the Global Industry

The global multiple myeloma market size is projected to reach USD 31 billion by the end of 2026. The high prevalence of the disease will emerge in favor of the companies operating in the market. According to a report published by Fortune Business Insights, titled “Multiple Myeloma Market Size, Share & Industry Analysis, By Drug Class (Immunomodulators, Proteasome Inhibitor, Anti-CD38 Monoclonal Antibody, Alkylating Agents, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies), and Regional Forecast, 2019-2026,” the market was worth USD 19.48 billion in 2018 and will exhibit a CAGR of 6.0% during the forecast period, 2019-2026.

 

Detailed Table of Content:

 

  1. Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  4. Key Insights
    • Prevalence of Multiple Myeloma – by Key Countries – 2018
    • Pipeline Analysis
    • Key Industry Developments
    • Regulatory Scenario, by Key Regions
    • Analysis Of Economic Burden of Multiple Myeloma Treatment
    • New Product Launches
    • Overview of Emerging Treatments for Multiple Myeloma
  5. Global Multiple Myeloma Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Drug Class
      • Immunomodulators
      • Proteasome Inhibitor
      • Anti-CD38 Monoclonal Antibody
      • Alkylating Agents
      • Others
    • Market Analysis, Insights and Forecast – By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies & Drug Stores
      • Online Pharmacies
    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East & Africa
  1. North America Multiple Myeloma Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary
    • Market Analysis – By Drug Class
      • Immunomodulators
      • Proteasome Inhibitor
      • Anti-CD38 Monoclonal Antibody
      • Alkylating Agents
      • Others
    • Market Analysis – By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies & Drug Stores
      • Online Pharmacies
    • Market Analysis – By Country
      • S.
      • Canada
  1. Europe Multiple Myeloma Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary
    • Market Analysis – By Drug Class
      • Immunomodulators
      • Proteasome Inhibitor
      • Anti-CD38 Monoclonal Antibody
      • Alkylating Agents
      • Others
    • Market Analysis – By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies & Drug Stores
      • Online Pharmacies
    • Market Analysis – By Country/ sub-region
      • K.
      • Germany
      • France
      • Spain
      • Italy
      • Scandinavia
      • Rest of Europe
  1. Asia pacific Multiple Myeloma Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary
    • Market Analysis – By Drug Class
      • Immunomodulators
      • Proteasome Inhibitor
      • Anti-CD38 Monoclonal Antibody
      • Alkylating Agents
      • Others
    • Market Analysis – By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies & Drug Stores
      • Online Pharmacies
    • Market Analysis – By Country/ sub-region
      • Japan
      • China
      • India
      • Australia
      • Southeast Asia
      • Rest of Asia Pacific
  1. Latin America Multiple Myeloma Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary
    • Market Analysis – By Drug Class
      • Immunomodulators
      • Proteasome Inhibitor
      • Anti-CD38 Monoclonal Antibody
      • Alkylating Agents
      • Others
    • Market Analysis – By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies & Drug Stores
      • Online Pharmacies
    • Market Analysis – By Country/ sub-region
      • Brazil
      • Mexico
      • Rest of Latin America
  1. Middle East & Africa Multiple Myeloma Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary
    • Market Analysis – By Drug Class
      • Immunomodulators
      • Proteasome Inhibitor
      • Anti-CD38 Monoclonal Antibody
      • Alkylating Agents
      • Others
    • Market Analysis – By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies & Drug Stores
      • Online Pharmacies
    • Market Analysis – By Country/ sub-region
      • GCC Countries
      • South Africa
      • Rest of Middle East & Africa

Continued…

 

Reasons to Purchase this Report:

 

  • Comprehensive analysis of the Multiple Myeloma Market growth drivers, obstacles, opportunities, and other related challenges.
  • Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
  • Identifies market restraints and boosters.
  • Identifies all the possible segments present in the market to aid organizations in strategic business planning.

Next-generation Sequencing Market

Rehabilitation Robots Market

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close